[Psychostimulants for late life depression]

Area of Science:

• Geriatric Psychiatry
• Pharmacological Treatments
• Mental Health Research

Background:

• Psychostimulant use for depressive disorders is gaining attention.
• There is a specific interest in their application for geriatric depression.

Purpose of the Study:

• To review existing literature on psychostimulants for treating depression in older adults.
• To assess the efficacy and tolerability of these treatments.

Main Methods:

• Literature review of studies published between 1980 and 2016.
• Inclusion criterion: average participant age of 60 years or older.
• Analysis of 12 trials (3 controlled, 9 uncontrolled).

Main Results:

• Methylphenidate was the most frequently studied psychostimulant.
• Evidence suggests potential efficacy as an add-on therapy for late-life depression.
• The level of proof for efficacy remains largely insufficient.

Conclusions:

• Small sample sizes and methodological limitations hinder definitive conclusions.
• Further rigorous studies are needed, especially for treatment-resistant depression in the elderly.